Free Trial
NASDAQ:TRAW

Traws Pharma (TRAW) Stock Price, News & Analysis

Traws Pharma logo
$2.86 +0.19 (+7.12%)
Closing price 10/17/2025 04:00 PM Eastern
Extended Trading
$2.78 -0.08 (-2.80%)
As of 10/17/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Traws Pharma Stock (NASDAQ:TRAW)

Advanced

Key Stats

Today's Range
$2.64
$2.90
50-Day Range
$1.33
$3.13
52-Week Range
$0.97
$19.44
Volume
125,941 shs
Average Volume
249,184 shs
Market Capitalization
$20.39 million
P/E Ratio
0.03
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Traws Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
17th Percentile Overall Score

TRAW MarketRank™: 

Traws Pharma scored higher than 17% of companies evaluated by MarketBeat, and ranked 872nd out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Traws Pharma is 0.03, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 225.12.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Traws Pharma is 0.03, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.54.

  • Read more about Traws Pharma's valuation and earnings.
  • Percentage of Shares Shorted

    2.21% of the float of Traws Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Traws Pharma has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Traws Pharma has recently increased by 12.33%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Traws Pharma does not currently pay a dividend.

  • Dividend Growth

    Traws Pharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.21% of the float of Traws Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Traws Pharma has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Traws Pharma has recently increased by 12.33%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Traws Pharma has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Traws Pharma this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Traws Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    14.00% of the stock of Traws Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 7.95% of the stock of Traws Pharma is held by institutions.

  • Read more about Traws Pharma's insider trading history.
Receive TRAW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Traws Pharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TRAW Stock News Headlines

Nvidia CEO Makes First Ever Tesla Announcement
While headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $25 trillion AI revolution — one that Nvidia’s CEO himself has called a “multi-trillion-dollar future industry” — and he’s uncovered a little-known stock 168 times smaller than Nvidia that could be positioned to ride this breakthrough.tc pixel
See More Headlines

TRAW Stock Analysis - Frequently Asked Questions

Traws Pharma's stock was trading at $8.88 on January 1st, 2025. Since then, TRAW shares have decreased by 67.8% and is now trading at $2.86.

Traws Pharma, Inc. (NASDAQ:TRAW) released its quarterly earnings results on Thursday, August, 14th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($8.75) by $8.64. The business had revenue of $2.73 million for the quarter, compared to the consensus estimate of $0.06 million. Traws Pharma had a negative trailing twelve-month return on equity of 1,812.48% and a net margin of 3,028.25%.
Read the conference call transcript
.

Shares of TRAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Traws Pharma investors own include Clearside Biomedical (CLSD), Evofem Biosciences (EVFM), Sirius XM (SIRI), Adverum Biotechnologies (ADVM) and Aptinyx (APTX).

Company Calendar

Last Earnings
8/14/2025
Today
10/18/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TRAW
Previous Symbol
NASDAQ:TRAW
CIK
1130598
Employees
17
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$88.83
Trailing P/E Ratio
0.03
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$166.52 million
Net Margins
3,028.25%
Pretax Margin
-613.92%
Return on Equity
-1,812.48%
Return on Assets
512.72%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.09
Quick Ratio
2.09

Sales & Book Value

Annual Sales
$230 thousand
Price / Sales
88.66
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($8.66) per share
Price / Book
-0.33

Miscellaneous

Outstanding Shares
7,130,000
Free Float
6,128,000
Market Cap
$20.39 million
Optionable
Optionable
Beta
1.69
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:TRAW) was last updated on 10/19/2025 by MarketBeat.com Staff
From Our Partners